Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rivaroxaban × Myeloid × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 12 Tumor-Agnostic 1 Thoracic 1 Myeloid 1 Gynecologic 1

Conditions

Myeloproliferative Disorders 1

Interventions

fludarabine phosphate 122 Cyclophosphamide 115 Imatinib Mesylate 87 Busulfan 83 Peripheral Blood Stem Cell Transplantation 76 Mycophenolic Acid 75 Azacitidine 75 Cytarabine 73 Cyclosporine 68 fludarabine 65 Whole-Body Irradiation 65 Tacrolimus 61 Antilymphocyte Serum 61 Filgrastim 55 nilotinib 52 Methotrexate 51 Melphalan 47 Decitabine 46 Radiotherapy 37 Dasatinib 30 ruxolitinib 29 thymoglobulin 28 Granulocyte Colony-Stimulating Factor 28 Clofarabine 27 Etoposide 26 Thiotepa 25 Stem Cell Transplantation 23 Methylprednisolone 23 Cord Blood Stem Cell Transplantation 23 sargramostim 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04192916 2021-02-21

MPN-DOACs

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡